Alembic Limited (BOM:506235)

India · Delayed Price · Currency is INR

92.73

+1.30 (1.42%)

At close: Aug 21, 2026

-14.10% (1Y)

Market Cap	23.81B -14.1%
Revenue (ttm)	2.39B +8.2%
Net Income	3.21B +1.3%
EPS	12.49 +1.3%
Shares Out	256.78M
PE Ratio	7.42
Forward PE	n/a
Dividend	2.40 (2.71%)
Ex-Dividend Date	Aug 4, 2026

Volume	56,656
Open	91.81
Previous Close	91.43
Day's Range	90.60 - 93.19
52-Week Range	70.64 - 109.75
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Alembic

Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredients; and research and development activities. In addition, the company is involved in power generation through co-generat... [Read more]

Industry Real Estate

Founded 1907

Employees 261

Stock Exchange Bombay Stock Exchange

Ticker Symbol 506235

Full Company Profile

Financial Performance

In fiscal year 2026, Alembic's revenue was 2.40 billion, an increase of 8.16% compared to the previous year's 2.22 billion. Earnings were 3.17 billion, an increase of 2.16%.

Financial Statements